Delivery Order SPE2DB20D1100-SPE2DB25FA1W3

Award Date 1/21/25
Potential Completion Date 1/22/25
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML medical supplies to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and has a ceiling value of $1,757.25. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML medical supplies. The contract, valued at $4,197.25, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 8, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This federal contract award is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML medical supplies. The award was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,588.28 and runs through February 19, 2025. It is a firm fixed-price delivery order contract, without any set-aside designation. Amerisourcebergen Drug Corp holds a larger...
This federal contract award is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML medical products to the Defense Logistics Agency (DLA). The contract, valued at $1,738.17, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of November 19, 2024. The contract is not associated with a set-aside designation,...
This federal contract award is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML medical supplies to the Defense Logistics Agency (DLA). The contract, valued at $5,407.96, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, and the ultimate completion date is January 7, 2025. The contract is not designated with a set-aside requirement, indicating open...
This federal contract award is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML medical products to the Defense Logistics Agency (DLA). The contract, valued at $1,081.24, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, and the ultimate completion date is November 26, 2024. The contract is not designated with a set-aside requirement, indicating open...
This federal contract award is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $1,073.54 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 12, 2024, with a completion date of December 13, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML medical supplies to the Defense Logistics Agency (DLA), a defense agency. The contract has a total ceiling value of $2,382.85 and is a firm fixed-price delivery order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. This contract is not set aside and is part of Amerisourcebergen's larger...
This federal contract award is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a pharmaceutical distribution company, and has a ceiling value of $1,318.08. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC is valued at up to $999,999,999.00 and runs...
This contract award is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML medical supplies to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $7,552.24. The contract has an ultimate completion date of January 22, 2025 and is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FA1W3
    Delivery Order

This federal contract award is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML medical supplies. The award, valued at $2,687.49, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical division. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition.

Generated 5/21/25, 9:55 AM